foxo4-dri patent Research Peptide – 15mg FOXO4-Dri 10mg - Polaris Peptides
FOXO4 Dri 10mg Polaris Peptides The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOXO4 DRI Wikipedia FOXO4 DRI PEPTIDE 2MG 5MG 10MG VIAL UMBRELLA Labs
Pay in 4 interest-free payments of $5.69 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11




